检索

标题
作者
Intermediate results of the PERFECTION observational study in a population of patients with metastatic, persistent and recurrent cervical cancer
Saevets V., Kuzmin N., Ponomareva N., Krashikhina T., Mochalova A., Vasilyev L., Stroyakovsky D., Kolomiets L., Averyanova S., Yavorskaya M., Orlova S., Boskhomjieva M., Peganova E., Shalina A., Kosukhina A., Khaikin A., Shkradyuk A., Bobrova E., Dikhtyar T., Shikina V., Sultanbaev A., Kudryavtsev I., Zinkina-Orikhan A., Fogt S., Kiseleva P., Svechnikov E.
Safety of Pembroria® during non-medical switching from Keytruda® in patients with advanced malignant neoplasms of various localizations: the REFLECTION real-world study
Choynzonov E., Fedenko A., Falaleeva N., Andreeva T., Afanas'ev S., Bakaev Z., Valiev D., Volkov A., Kolomiets L., Krashikhina T., Miller S., Mikhaliuk V., Ogloblin A., Orlova S., Pataliak S., Pokataev I., Popova N., Rebrina O., Safin R., Stradaeva I., Trefilova I., Usol'tseva I., Usynin E., Sharov S., Iukal'chuk D., Iasieva A.
Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study
Volkova M., Kalpinskiy A., Goncharova O., Menshikov K., Karabina E., Dergunov A., Polshina N., Alexandrova E., Lebedinets A., Panov A., Sultanbaev A., Usynin E., Volkonskiy M., Mikhalyuk V., Zukov R., Anzhiganova Y., Gusniev M., Igumnova E., Kuzmicheva S., Pokataev I., Olshanskaya A., Pervakova N., Parsadanova E., Sannikova T., Bystrov A., Dubovichenko D., Miliausha M., Chubenko V., Shkret K., Gorshenina M., Davlatova M., Kosareva A., Lutoshkina O., Maslova O., Makhnutina M., Mishina A., Murzalina M., Podyacheva O., Kalinin S., Mailyan O., Safarova A., Semenova K., Strokova M., Urashkina E., Shmygina O.
Real-world efficacy and safety of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: Updated data from a Russian observational study
Volkova M., Kalpinskiy A., Goncharova O., Menshikov K., Stativko O., Karabina E., Dergunov A., Polshina N., Alexandrova E., Lebedinets A., Panov A., Sultanbaev A., Usynin E., Volkonskiy M., Mikhalyuk V., Zukov R., Anzhiganova Y., Gusniev M., Igumnova E., Kuzmicheva S., Pokataev I., Olshanskaya A., Pervakova N., Parsadanova E., Sannikova T., Bystrov A., Dubovichenko D., Mukhitova M., Chubenko V., Shkret K., Gorshenina M., Semenov A., Davlatova M., Kosareva A., Lutoshkina O., Maslova O., Tarasova A., Mishina A., Murzalina M., Podyacheva O., Kalinin S., Mailyan O., Safarova A., Semenova K., Strokova M., Urashkina E., Shmygina O.
News in immunotherapy for metastatic melanoma: prolgolimab in clinical practice (authors' experience)
Oganesyan L., Karnaukhov N., Feoktistova P.
Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review
Zukov R., Chernyaev D., Zulkaidarova A.
Interim results analysis of the PERFECTION observational study in patients with metastatic non-small cell lung cancer
Laktionov K., Fedyanin M., Stroyakovskiy D., Mochalova A., Iasieva A., Fadeeva N., Shapovalova I., Mironov O., Dergunov A., Orlov S., Vasilev L., Bobrova E., Orlova S., Kosukhina A., Polshina N., Vardanian S., Fedoseev A., Tumasian K., Danilova A., Krashikhina T., Tsygankova E., Staritsyn D., Toporkova O., Boskhomdzhieva M., Sultanbaev A., Edamenko M., Dmitriev V., Shkradiuk A., Shkret K., Prosianikova O., Svechnikov E., Grigorchuk S.
Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report
Protasova A., Strakh L., Lando E., Sidorkina E.
First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx
Stativko O., Pokataev I., Kravtsov S., Zhukova L., Stroyakovskiy D., Sabitov E., Kuzmina E., Feoktistova P., Antonova T., Lyadova M., Nosova M., Sydykova R., Lisitsyna K., Strelnikova T., Alizade G., Parts S., Dolov M., Tedeeva A., Galkin V.
Hodgkin lymphoma. ASCO, EHA and ASH 2020 news
Demina E.
The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study
Pokataev I., Stroyakovskiy D., Fedyanin M., Zhukova L., Stativko O., Andreyashkina I., Volkova M., Volkonskiy M., Polshina N., Kotova E., Kravchuk D., Bystrov A., Antonova T., Lyadova M., Kuzmina E., Parts S., Salpagarov M., Galkin V., Klimov A.
Use of nivolumab for colon cancer with Lynch syndrome
Khakimov G., Tryakin A., Khakimova G.
Retrospective analysis of the safety and efficacy of Pembroria® during non-medical switching from the original drug Keytruda® in patients with advanced malignancies of various localizations in real clinical practice
Zhukova L., Filonenko D., Polshina N., Smolin S., Pasechnyuk O.
1 - 13 的 13 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).